13F-HR filed by Affinity Asset Advisors, LLC
Affinity Asset Advisors, LLC filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-14, with 98 holding rows worth $1,047,782,894.
- Accession
- 0001999371-25-006074
- Filer
- CIK 1773195
- Filed
- 2025-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 98 entries on the cover page, a total value of $1,047,782,894 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,047,782,894 with VALUE read as dollars as filed, 13F file number 028-20754. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPY | 78462F103 | SHS | 400,000 | $223,756,000 | dollars as filed | put |
| iShares Russell 2000 ETF | 464287655 | SHS | 300,000 | $59,847,000 | dollars as filed | put |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,328,175 | $44,560,271 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 1,151,199 | $43,008,795 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 500,000 | $40,550,000 | dollars as filed | put |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 615,000 | $39,046,350 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 530,000 | $34,768,000 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 1,000,000 | $33,020,000 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 460,000 | $32,623,200 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 80,000 | $26,498,400 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 1,546,662 | $22,241,000 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 70,000 | $21,808,500 | dollars as filed | call |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,400,000 | $21,518,000 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 400,000 | $19,344,000 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 1,070,000 | $19,174,400 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 1,100,000 | $17,468,000 | dollars as filed | |
| SPY | 78462F103 | SHS | 30,000 | $16,781,700 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 55,000 | $14,851,100 | dollars as filed | call |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 1,825,000 | $14,746,000 | dollars as filed | |
| OMEROS CORP | 682143AG7 | NOTE 5.250% 2/1 | 15,525,000 | $14,275,238 | dollars as filed | principal |
| MERUS N V | N5749R100 | COM | 321,962 | $13,551,381 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 100,000 | $11,663,000 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576UAA4 | BOND | 15,250,000 | $11,611,232 | dollars as filed | principal |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 280,000 | $11,425,400 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 140,000 | $10,680,600 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 300,000 | $10,371,000 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 810,669 | $9,630,748 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 355,143 | $8,530,535 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 172,500 | $8,342,100 | dollars as filed | call |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 70,000 | $7,995,400 | dollars as filed | call |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 1,250,000 | $7,862,500 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 481,678 | $7,771,875 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 430,000 | $7,348,700 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422GAA5 | CNV | 7,000,000 | $6,993,000 | dollars as filed | principal |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 325,000 | $6,652,750 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 265,000 | $6,365,300 | dollars as filed | call |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 545,362 | $5,595,414 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 50,000 | $5,530,000 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 657,154 | $5,263,804 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 390,000 | $5,257,200 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 1,480,881 | $5,138,657 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 152,252 | $5,106,532 | dollars as filed | |
| EXELIXIS INC COM | 30161Q104 | Stock | 135,000 | $4,984,200 | dollars as filed | call |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 1,700,000 | $4,930,000 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 2,224,196 | $4,737,537 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 3,045,000 | $4,719,750 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 3,341,519 | $4,577,881 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 200,000 | $4,400,000 | dollars as filed | put |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 3,284,512 | $4,368,401 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 400,000 | $4,240,000 | dollars as filed | |
| PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | CL A ORD SHS | 350,000 | $3,619,000 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 50,000 | $3,572,500 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 3,867,710 | $3,519,616 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 200,000 | $3,176,000 | dollars as filed | put |
| IMMUNITYBIO INC | 45256X103 | COM | 1,025,000 | $3,085,250 | dollars as filed | put |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 1,500,000 | $2,880,000 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 250,000 | $2,752,500 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 241,957 | $2,746,212 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 100,000 | $2,737,000 | dollars as filed | |
| OAKTREE ACQUISITION CORP III | G6717R120 | UNIT 10/04/2029 | 250,000 | $2,595,000 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 1,330,700 | $2,528,330 | dollars as filed | put |
| GERON CORP | 374163103 | COM | 1,500,000 | $2,385,000 | dollars as filed | |
| MONOPAR THERAPEUTICS INC | 61023L207 | COMMON STOCK | 62,000 | $2,257,420 | dollars as filed | |
| GALECTIN THERAPEUTICS INC | 363225202 | COMMON STOCK | 1,836,200 | $2,240,164 | dollars as filed | put |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 49,692 | $2,238,625 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 99,800 | $2,042,906 | dollars as filed | call |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 800,000 | $2,008,000 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 263,817 | $1,997,095 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 1,500,000 | $1,830,000 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 394,159 | $1,694,884 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 75,000 | $1,535,250 | dollars as filed | put |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 100,000 | $1,521,000 | dollars as filed | call |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 150,000 | $1,513,500 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 800,000 | $1,472,000 | dollars as filed | |
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 390,000 | $1,419,600 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 175,000 | $1,291,500 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 370,000 | $1,283,900 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 175,000 | $1,272,250 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 200,000 | $1,250,000 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 325,000 | $1,222,000 | dollars as filed | |
| NEXTCURE INC | 65343E108 | COM | 2,302,598 | $1,105,938 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 150,000 | $1,017,000 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 25,000 | $944,000 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 25,000 | $603,750 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 752,722 | $489,721 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 660,589 | $404,280 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 250,000 | $387,500 | dollars as filed | |
| RADIOPHARM THERANOSTICS LTD | 75041J101 | SPONSORED ADS | 64,600 | $310,726 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 223,335 | $288,102 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 130,807 | $248,533 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 667,516 | $208,198 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 200,000 | $197,180 | dollars as filed | |
| Adagio Med Hldgs Inc Com | 00534B100 | Common Stock | 213,235 | $169,543 | dollars as filed | |
| OMEROS CORP | 682143102 | COM | 9,958 | $81,855 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 250,000 | $56,900 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 27,777 | $45,832 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 75,000 | $3,525 | dollars as filed | |
| IMMATICS N.V | N44445117 | *W EXP 07/01/202 | 187,204 | $2,958 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001999371-25-006074 | this filing | 2025-05-14 | acceptance time not in the bulk data set |